ESCAPE-NEXT is a multicentre, randomized, double-blinded, placebo-controlled, parallel Group, singledose trial designed to determine the efficacy and safety of nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis.
ESCAPE-NEXT is a custom designed Electronic Data Capture (EDC), Randomization and Drug Management (RDM) Interactive Resposive Technology (IRT) developed for the purpose of facilitating the data collection for the ESCAPE-NEXT Trial, while providing the following functions:
Other Links:
At heart, we are a dynamic and open-minded group of individuals that want to help companies succeed. First and foremost, we are critical thinkers and problem solvers.
Contact Us